IDiyas

For the Inventor, By the Inventor

Salt Lake City, UT, United States of America

Lipocine Inc.


USPTO Granted Patents = 39



Trademarks = 6

Forward Citations = 5,879

Loading Chart...
Loading Chart...

28 inventors (with patents filed for the assignee):

goldMedal Mahesh V Patel (39 out of 92 patents)

silverMedal Chandrashekar Giliyar (23 out of 33 patents)

bronzeMedal Nachiappan Chidambaram (21 out of 66 patents)

4.  Basawaraj Chickmath (19 out of 26 patents)

5.  Srinivasan Venkateshwaran (15 out of 38 patents)

6.  Feng-Jing Chen (14 out of 14 patents)

7.  Srinivansan Venkateshwaran (11 out of 18 patents)

8.  Satish Kumar Nachaegari (10 out of 27 patents)

9.  Chidambaram Nachiappan (4 out of 5 patents)

10.  Joel Frank (2 out of 5 patents)

11.  David T Fikstad (2 out of 3 patents)

12.  Steven L Krill (1 out of 1 patent)

13.  Feng-Jing Chen (13 patents)

14.  Kilyoung Kim (8 patents)

15.  David Fikstad (0 patent)


39 patents:

1. 11052096 - Steroidal compositions (2021-07-06),
2. 10973833 - High-strength testosterone undecanoate compositions (2021-04-13),
3. 10799513 - High-strength testosterone undecanoate compositions (2020-10-13),
4. 10716794 - High-strength testosterone undecanoate compositions (2020-07-21),
5. 10709716 - 17-hydroxyprogesterone ester-containing oral compositions and related methods (2020-07-14),
6. 10561615 - Testosterone undecanoate compositions (2020-02-18),
7. 10226473 - High-strength testosterone undecanoate compositions (2019-03-12),
8. 10022384 - 17-hydroxyprogesterone ester-containing oral compositions and related methods (2018-07-17),
9. 9949985 - High-strength testosterone undecanoate compositions (2018-04-24),
10. 9943527 - High-strength testosterone undecanoate compositions (2018-04-17),
11. 9757390 - High-strength testosterone undecanoate compositions (2017-09-12),
12. 9757389 - Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters (2017-09-12),
13. 9498485 - Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters (2016-11-22),
14. 9480690 - High-strength testosterone undecanoate compositions (2016-11-01),
15. 9399069 - 17-Hydroxyprogesterone ester containing oral compositions and related methods (2016-07-26),
Lipocine Inc. is a specialty pharmaceutical company developing innovative oral drug delivery technologies for optimizing therapeutic outcomes. The company is focused on the development of oral testosterone replacement therapy and other products for men's and women's health. Lipocine has a diverse pipeline of potential pharmaceutical products in various stages of development. For more information, visit our website.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

...
39 Patents

#32 in Salt Lake City, UT

#92 in Utah

#8,539 in US

#16,923 in the World

...
Salt Lake City, UT, United States of America

Lipocine Inc.

Forward Citations = 5,879

28 inventors:

goldMedal Mahesh V Patel (39 out of 92 patents)

silverMedal Chandrashekar Giliyar (23 out of 33 patents)

bronzeMedal Nachiappan Chidambaram (21 out of 66 patents)

4.  Basawaraj Chickmath (19 out of 26 patents)

5.  Srinivasan Venkateshwaran (15 out of 38 patents)

Please report any incorrect information to support@idiyas.com
Loading…